Most people on Wegovy lose 15% to 20% of their starting body weight over about 68 to 72 weeks. For someone who starts at 230 pounds, that translates to roughly 35 to 43 pounds. A higher-dose version tested in clinical trials produced an average loss of 18.7% of body weight, while the standard 2.4 mg dose averaged 15.6%, both over 72 weeks. Your actual results depend on your starting weight, how consistently you take the medication, and the diet and exercise changes you make alongside it.
What Clinical Trials Show
The largest trials studying Wegovy enrolled adults with a BMI of 30 or higher, or a BMI of 27 to 29.9 with at least one weight-related health condition like high blood pressure or type 2 diabetes. All participants also followed a reduced-calorie diet and increased their physical activity. Under those conditions, the placebo group lost about 3.9% of their body weight, while the Wegovy group lost roughly four to five times more.
Because the trials report results as percentages, the number of pounds you lose scales with how much you weigh at the start. Here’s what 15% to 19% weight loss looks like at different starting weights:
- 200 pounds: 30 to 38 pounds lost
- 250 pounds: 38 to 47 pounds lost
- 300 pounds: 45 to 57 pounds lost
- 350 pounds: 53 to 67 pounds lost
These are averages. Some participants in the trials lost considerably more, and others lost less. About one-third of participants in the standard-dose trials lost 20% or more of their body weight.
When the Weight Comes Off
Wegovy uses a dose-escalation schedule, meaning you start at a low dose and gradually increase over several months. Weight loss follows that same gradual curve. In the first four weeks, people lose an average of about 2% of their starting body weight. That’s roughly 4 to 5 pounds for someone starting at 230.
By week 13, when the dose typically increases to 1.7 mg, average weight loss reaches about 8% of starting body weight. For a 250-pound person, that’s around 20 pounds in three months. The steepest losses tend to happen between months three and nine, as the medication reaches its full dose and appetite suppression is strongest.
After about 72 weeks, the average person on Wegovy can expect to have lost around 21% of their starting body weight. The pace of loss slows significantly in the second half of treatment, which brings us to plateaus.
Why Weight Loss Stalls
Nearly everyone on Wegovy hits a plateau at some point, and it doesn’t mean the medication has stopped working. Three things happen as you lose weight. First, your body simply needs fewer calories to function at a lower weight, so the same eating pattern that produced a deficit early on eventually becomes closer to maintenance. Second, people often move slightly less without realizing it, taking fewer steps or sitting more as energy intake drops. Third, not all the weight you lose is fat. Research suggests that 20% to 40% of weight lost on semaglutide comes from lean mass, including muscle, which further reduces the number of calories your body burns at rest.
Plateaus don’t mean you’ve gotten all the benefit you’re going to get. They’re a signal that your body has adapted to its new weight. Adding resistance training to preserve muscle, adjusting calorie intake, or simply being more deliberate about daily movement can help restart progress.
What Happens If You Stop
This is the part most people don’t hear about upfront. A systematic review published in eClinicalMedicine found that people regain about 60% of the weight they lost within one year of stopping a GLP-1 medication like Wegovy. If you lost 40 pounds on the drug, you could expect to regain roughly 24 of those pounds within 12 months of discontinuing.
That regain isn’t a failure of willpower. Wegovy works partly by reducing hunger signals and slowing how quickly food leaves your stomach. When the medication is removed, those biological drivers of appetite return. This is why most prescribers frame Wegovy as a long-term or even indefinite treatment rather than a short course you take until you hit your goal weight.
How Wegovy Produces Weight Loss
Wegovy’s active ingredient mimics a hormone your gut naturally releases after eating. That hormone tells your brain you’re full, reduces appetite between meals, and slows the rate at which food moves through your stomach. The combined effect is that you feel satisfied with less food and think about eating less often throughout the day. Most people describe it as the “food noise” in their head going quiet.
The medication is injected once a week using a prefilled pen, similar to the devices used for insulin. You start at the lowest dose (0.25 mg) and step up every four weeks until reaching the maintenance dose, which takes about 16 to 20 weeks. Side effects are most common during dose increases, with nausea being the most frequently reported. For most people it’s mild and fades within a few weeks at each new dose level.
Who Qualifies for a Prescription
The FDA approves Wegovy for adults with obesity, defined as a BMI of 30 or higher, or adults with a BMI of 27 to 29.9 who also have at least one weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol. It’s also approved for adolescents aged 12 and older whose BMI is at or above the 95th percentile for their age and sex.
Insurance coverage varies widely. Some plans cover Wegovy with prior authorization, while others exclude weight-management medications entirely. Without insurance, the list price is significant, which is why many people cycle on and off the drug or look for manufacturer savings programs. If you’re considering Wegovy primarily for the pound number on the scale, it helps to weigh that number against the reality that sustained results typically require sustained use.